St. Jude Medical Reports Third Quarter 2015 Results

Go back to St. Jude Medical Reports Third Quarter 2015 Results

Canaccord Genuity Cuts Price Target on St. Jude Medical (STJ) Following In-Line 3Q Results

October 22, 2015 10:09 AM EDT

Canaccord Genuity maintained a Sell rating on St. Jude Medical (NYSE: STJ), and cut the price target to $59.00 (from $64.00), following the company's 3Q15 earnings results. While Q3 top- and bottom-line performance was largely in line with expectations, there was notable weakness in several key... More

Stifel Downgrades St. Jude Medical (STJ) to Hold

October 22, 2015 7:08 AM EDT

Stifel downgraded St. Jude Medical (NYSE: STJ) from Buy to Hold and removed its price target (prior $89.00).

For an analyst ratings summary and ratings history on St. Jude Medical click here. For more ratings news on St. Jude Medical click here.

Shares of St. Jude Medical closed at $62.30 yesterday.

... More

St. Jude Medical (STJ) Reports In-Line Q3 EPS

October 21, 2015 7:17 AM EDT

St. Jude Medical (NYSE: STJ) reported Q3 EPS of $0.97, in-line with the analyst estimate of $0.97. Revenue for the quarter came in at $1.34 billion versus the consensus estimate of $1.35 billion.

St. Jude Medical sees Q4 2015 EPS of $1.00-$1.02, versus the consensus of... More